AwardTape · Defense awards · Gateway Biotechnology, Inc
Gateway Biotechnology, Inc: $650K in DoD and DHS awards
Gateway Biotechnology, Inc holds 1 DoD and DHS prime award with $650K obligated May 23, 2025 to Apr 23, 2026. Largest category: Health R&D at $650K; largest buyer: Defense Health Agency at $650K.
| Obligated FY2024+ | $650K |
|---|---|
| Awards | 1 |
| FY2024 | $0 |
| FY2025 | $0 |
| FY2026 to date | $650K |
| Lifetime obligated on these awards | $1.9M |
| First and latest action | May 23, 2025 · Apr 23, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Health R&D | $650K | 1 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $650K | 1 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT942523C0071 definitive contract | $650K | Medical research and development contract DHA sbir ph ii, proposal no. h2s-0048, titled: "gw-tt2, a new drug product for tinnitus" | Defense Health Agency | Health R&D | Apr 23, 2026 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial